|

Placebo for BCAA Clinical Trials

1 actively recruiting trial

Pipeline

Phase 4: 1

Top Sponsors

  • Post Graduate Institute of Medical Education and Research, Chandigarh1

Indications

  • Minimal Hepatic Encephalopathy1
  • Decompensated Cirrhosis1
  • Liver Disease1
  • Hepatic Encephalopathy1

Other1 trial

BCAA vs. Rifaximin in Patients With Cirrhosis for Secondary Prophylaxis of HE
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.